Today, you're getting four brand new dossiers on IPOs (or RTOs) that we believe will give you a chance at some extraordinary gains. One is a company with an impressive take on cannabis delivery - and it should be in your portfolio as soon as possible.
The short-seller's allegations focus only on Aphria and one other small company. It has nothing to do with other cannabis stocks. Also, the negative report carries less substance than mainstream headline writers want to believe.
The biggest winners, hands down, in the Canadian cannabis supply shortage are all of the smaller, later-to-market producers. It buys them time to get to market, and it will take longer for the first wave of suppliers who are already in stores to build up the brand loyalty they were counting on.
With the biggest opponent to cannabis out of the way, the federal government has an easier path to pro-cannabis measures. That will open up the floodgates for publicly traded cannabis firms, especially those operating in the United States.
When downturns hit a cannabis stock, that can be a good thing - It creates opportunity following the immediacy of the bad news. Even investing legends will tell you that it's a fool's errand trying to pick the exact lowest price as the only time to get in on a stock.